Adolescent Health Scope for FNP Practice
Adolescent health encompasses the physical, psychosocial, and developmental needs of patients aged approximately 11–21 years. This period is marked by rapid growth, pubertal changes, identity formation, and increased risk-taking behaviors. For the FNP exam, mastery of preventive care, screening guidelines, and confidential services is essential. High-yield topics include immunizations, mental health screening, substance use assessment, and reproductive health.[1]
Core Terminology Using the HEEADSSS Approach
- Adolescence: Transitional stage from childhood to adulthood, divided into early (11–14), middle (15–17), and late (18–21) phases.
- HEEADSSS assessment: A psychosocial interview framework used to evaluate Home, Education/Employment, Eating, Activities, Drugs, Sexuality, Suicide/Depression, Safety.[2]
- Confidentiality: Legal and ethical obligation to protect adolescent health information; state laws vary regarding minor consent for certain services (e.g., STI testing, contraception).
- HPV vaccine: Recommended at age 11–12; catch-up through age 26.[3]
- Menarche: First menstrual period, typically occurring between ages 10–15.
Health Maintenance and Developmental Stages in Adolescence
Developmental Stages
- Early adolescence (11–14): Concrete thinking, body image concerns, peer influence begins.
- Middle adolescence (15–17): Abstract reasoning develops, increased risk-taking, identity exploration.
- Late adolescence (18–21): Future-oriented thinking, mature relationships, independent decision-making.
Routine Health Maintenance
- Annual well-visit with HEEADSSS assessment.
- Immunizations: Tdap, HPV series, meningococcal conjugate (MenACWY), and serogroup B (MenB) if indicated.[4]
- Screenings: Depression (PHQ-9), substance use (CRAFFT), BMI, blood pressure, vision, hearing, and scoliosis (if clinically indicated).
- Confidential time alone with provider per AAP recommendations.[1]
Preventive Counseling
- Discuss sexual health: abstinence, contraception, STI prevention, HPV vaccine.
- Address nutrition and physical activity to prevent obesity and eating disorders.
- Screen for mental health disorders (depression, anxiety, suicide risk).
- Promote injury prevention: seatbelt use, helmet use, firearm safety.
Common Clinical Presentations in Adolescents
Common Conditions Encountered in Adolescent Health
- Acne vulgaris: Comedones, papules, pustules; may require topical or systemic therapy.
- Dysmenorrhea: Cyclical pelvic pain; first-line NSAIDs, consider hormonal contraception.
- Scoliosis: Lateral curvature >10° on X-ray; refer for bracing or surgery if curvature >25–30°.
- Eating disorders: Anorexia nervosa (restrictive), bulimia nervosa (binge-purge), OSFED; screen with SCOFF questionnaire.
- Depression: Persistent sadness, anhedonia, changes in sleep/appetite, suicidal ideation.
Screening Tools and Growth Monitoring in Adolescents
Screening Tools
| Domain | Screening Tool | Key Points |
|---|---|---|
| Substance use | CRAFFT | 6 questions (Car, Relax, Alone, Friends, Forget, Trouble); score ≥2 indicates high risk.[5] |
| Depression | PHQ-9 | Validated for ages 12+; score ≥10 indicates moderate depression. |
| Eating disorder | SCOFF | 5 questions; 2+ "yes" warrants further evaluation. |
| Blood pressure | Percentile per age/height | Use normative tables; elevated if ≥90th percentile. |
Growth and Development Monitoring
- Plot height, weight, and BMI on CDC growth charts.
- Tanner staging (sexual maturity rating) for pubertal progression.
- Assess for delayed or precocious puberty: onset of breast development before age 8 (girls) or testicular enlargement before age 9 (boys).
Vaccination, Mental Health, and Reproductive Interventions
Vaccination Schedule (Ages 11–18)
- Tdap: Single dose at age 11–12.
- HPV: 2-dose series if started before 15; 3-dose series if started at 15 or older.[3]
- MenACWY: first dose at 11–12, booster at 16.
- MenB: shared clinical decision-making for ages 16–23; routinely recommended for high-risk conditions.
Mental Health Interventions
- Depression: Cognitive-behavioral therapy (CBT), SSRIs (fluoxetine approved for adolescents).
- Suicide risk: Immediate safety plan, crisis hotline number, referral to mental health specialist.
- Anxiety: CBT, selective serotonin reuptake inhibitors (SSRIs) as second-line if therapy insufficient.
Reproductive Health Counseling
- Confidential contraception: oral contraceptives, implant, IUD, Depo-Provera.
- Emergency contraception: ulipristal (Ella) or levonorgestrel (Plan B).
- STI screening: chlamydia/gonorrhea testing annually for sexually active females; consider for males based on risk.
- HIV pre-exposure prophylaxis (PrEP) for high-risk adolescents (discuss adherence and follow-up).
Risk Management and Safety in Adolescent Practice
- Confidentiality breaches: Know state laws; mandatory reporting for abuse, suicidal/homicidal ideation, and certain infectious diseases.
- Medication interactions: Hormonal contraception can interact with antiepileptics and antiretroviral agents.
- Weight-related concerns: Avoid exacerbating body image issues during BMI discussion; use neutral language.
- Depression treatment: Monitor for SSRI-induced activation or worsening suicidality, especially during first few weeks.
- Substance misuse: Educate on overdose risk, naloxone availability for opioid misuse.
Essential Testable Content for FNP Certification
- Memorize the HEEADSSS acronym – it appears frequently in case studies.
- Know that HPV vaccine is recommended at age 11–12 (not just for sexually active teens).
- Distinguish between confidentiality (protect patient disclosure) and mandatory reporting (e.g., abuse, danger to self/others).
- Understand Tanner staging for breast/genital development and pubic hair.
- Recall that depression screening is recommended for all adolescents 12+ per USPSTF.[6]
- For dysmenorrhea, first-line treatment is NSAIDs; if no response, consider hormonal contraception.
- Be aware that adolescent consent laws vary by state; common exceptions include STI treatment, contraception, prenatal care, and substance abuse counseling.
References and Sources
- American Academy of Pediatrics. Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 4th ed. Elk Grove Village, IL: AAP; 2017. https://doi.org/10.1542/9781610020237
- Klein DA, Goldenring JM, Adelman WP. HEEADSSS 3.0: The psychosocial interview for adolescents updated for a new century fueled by media. Contemp Pediatr. 2014;31(1):16-19. https://www.contemporarypediatrics.com/view/heeadsss-30-psychosocial-interview-adolescents-updated-new-century-fueled-media
- Centers for Disease Control and Prevention. HPV vaccine recommendations. MMWR. 2023. https://www.cdc.gov/vaccines/vpd/hpv/hcp/recommendations.html
- Centers for Disease Control and Prevention. Recommended immunization schedule for ages 7–18 years. MMWR. 2024. https://www.cdc.gov/vaccines/hcp/imz-schedules/downloads/past/2024-child.pdf
- Knight JR, Sherritt L, Shrier LA, et al. Validity of the CRAFFT substance abuse screening test among adolescent clinic patients. Arch Pediatr Adolesc Med. 2002;156(6):607-614. https://pubmed.ncbi.nlm.nih.gov/12038895/
- U.S. Preventive Services Task Force. Screening for depression in children and adolescents: recommendation statement. JAMA. 2022;327(23):2298-2306. https://pubmed.ncbi.nlm.nih.gov/26908686/